PJAM IBP Holdings, Inc.

SEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 8

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

IBP Holding Co · CIK 0001610199 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires not disclosed

F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 7

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

IBP Holding Co · CIK 0001610199 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 125,000 shares

Expires not disclosed

F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 6

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

IBP Holding Co · CIK 0001610199 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires not disclosed

F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 5

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

IBP Holding Co · CIK 0001610199 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 225,000 shares

Expires not disclosed

F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash.

F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027,

F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component.

F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component;

F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price.

F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements.

F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

IBP Holding Co · CIK 0001610199 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,727,819

F1 · price: PJAM IBP Holdings, Inc. ("PJAM") sold 400,000 shares of common stock of Installed Building Products, Inc. through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.

F2 · ownership.nature: These securities are held directly by PJAM. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001628280-25-053824 · wk-form4_1764019956.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

IBP Holding Co · CIK 0001610199 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,127,819

F1 · kind: Pursuant to the Issuer's previously announced stock buyback program, the Issuer entered into a Share Repurchase Agreement with PJAM IBP Holdings, Inc. ("PJAM") for the purchase of 150,000 shares of its common stock in a privately-negotiated transaction for an aggregate purchase price of $37,643,760. The repurchase was approved by the company's board of directors and is exempt from Section 16(b) by the virtue of Rule 16b-3(e).

F2 · ownership.nature: These securities are held directly by PJAM. The Reporting Persons, other than PJAM, disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001598688-25-000008 · wk-form4_1755723445.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

IBP Holding Co · CIK 0001610199 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,277,819

F1 · kind: Pursuant to the Issuer's previously announced stock buyback program, the Issuer entered into a Share Repurchase Agreement with PJAM IBP Holdings, Inc. ("PJAM") for the purchase of 200,000 shares of its common stock in a privately-negotiated transaction for an aggregate purchase price of $51,476,000. The repurchase was approved by the company's board of directors and is exempt from Section 16(b) by the virtue of Rule 16b-3(e). IBP Holding Company is the sole shareholder of PJAM.

F2 · ownership.nature: These securities are held directly by PJAM. The Reporting Persons, other than PJAM, disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein.

SEC source: 0000950170-25-036356 · ownership.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

IBP Holding Co · CIK 0001610199 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 2,477,819

F1 · kind: Pursuant to the Issuer's previously announced stock buyback program, the Issuer entered into a Share Repurchase Agreement with PJAM IBP Holdings, Inc. ("PJAM") for the purchase of 100,000 shares of its common stock in a privately-negotiated transaction for an aggregate purchase price of $16,875,000. The repurchase was approved by the company's board of directors and is exempt from Section 16(b) by virtue of Rule 16b-3(e). IBP Holding Company is the sole shareholder of PJAM.

F2 · ownership.nature: These securities are held directly by PJAM. The Reporting Persons, other than PJAM, disclaim beneficial ownership in the reported securities except to the extent of his or its pecuniary interest therein.

SEC source: 0000950170-24-097619 · ownership.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

IBP Holding Co · CIK 0001610199 · Director by Deputization

PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,577,819

F1 · kind: Pursuant to the Issuer's previously announced stock buyback program, the Issuer entered into a Share Repurchase Agreement with PJAM IBP Holdings, Inc. ("PJAM") for the purchase of 100,000 shares of its common stock in a privately-negotiated transaction for an aggregate purchase price of $20,690,000. The repurchase was approved by the company's board of directors and is exempt from Section 16(b) by virtue of Rule 16b-3(e). IBP Holding Company is the sole shareholder of PJAM.

F2 · ownership.nature: These securities are held directly by PJAM. The Reporting Persons, other than PJAM, disclaims pecuniary interest in the reported securities except to the extent of his or its economic interest therein.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 7

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,677,819

F7 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $118.52 to $119.19. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 6

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,679,931

F6 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $117.29 to $118.27. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 5

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,708,310

F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $116.26 to $117.21. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 4

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,747,819

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 3

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,747,919

F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $120.28 to $121.2750. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 2

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,760,261

F3 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $119.27 to $120.27. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-23-036363 · doc4.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,777,372

F1 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $118.26 to $119.26. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002435 · doc4.xml · nonDerivative · entry 3

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,797,819

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $128.19 to $129.00. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002435 · doc4.xml · nonDerivative · entry 2

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,800,917

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $127.17 to $128.15. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002435 · doc4.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,807,267

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $126.15 to $127.15. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 17

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,812,819

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F18 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $135.60 to $136.17. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 16

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,818,423

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F17 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $134.58 to $135.56. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 15

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,836,036

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F16 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $133.57 to $134.57. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 14

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,850,096

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F15 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $132.45 to $133.40. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 13

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,852,465

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F14 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $131.42 to $132.36. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 12

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,854,670

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F13 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $130.37 to $131.37. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 11

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,859,206

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F12 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $129.37 to $130.36. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 10

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,872,819

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F11 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $135.74 to $136.17. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 9

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,876,209

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F10 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $134.72 to $135.70. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 8

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,926,287

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F9 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $133.72 to $134.7150. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 7

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,947,819

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 6

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,948,235

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F8 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $138.86 to $139.05. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 5

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,948,735

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F7 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $137.73 to $138.55. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 4

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,952,735

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $136.67 to $137.60. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 3

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,958,815

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $135.43 to $136.35. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 2

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,965,718

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $134.43 to $135.42. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-22-002023 · doc4.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,983,773

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $133.43 to $134.4250. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 8

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,997,819

F9 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $132.63 to $133.305. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 7

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,012,907

F8 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $131.63 to $132.62. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 6

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,042,819

F7 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $132.60 to $133.1150. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 5

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,052,241

F6 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $131.60 to $132.59. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 4

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,113,327

F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $130.60 to $131.5950. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 3

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,167,819

F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $132.56 to $133.3650. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 2

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,171,623

F3 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $131.56 to $132.55. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-064351 · doc4.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,175,118

F1 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $130.55 to $131.54. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051426 · doc4.xml · nonDerivative · entry 1

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,197,819

F1 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $122.705 to $123.12. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051261 · doc4.xml · nonDerivative · entry 12

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,200,991

F13 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $128.11 to $129.00. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051261 · doc4.xml · nonDerivative · entry 11

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,201,831

F12 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $127.09 to $128.05. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051261 · doc4.xml · nonDerivative · entry 10

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,202,591

F11 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $126.00 to $126.52. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051261 · doc4.xml · nonDerivative · entry 9

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,207,118

F10 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $125.00 to $125.99. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.

SEC source: 0001209191-21-051261 · doc4.xml · nonDerivative · entry 8

Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner

PJAM IBP Holdings, Inc. · CIK 0001609973 · 10% owner · Director by Deputization

IBP Holding Co · CIK 0001610199 · 10% owner · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,292,819

F9 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $126.905 to $127.43. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: These securities are held directly by PJAM IBP Holdings, Inc. ("PJAM"). The Reporting Persons, other than PJAM, disclaim pecuniary interest in the reported securities except to the extent of his or its pecuniary interest therein. IBP Holding Company is the sole shareholder of PJAM.